Cadila Healthcare informs about press release

14 Feb 2022 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated February 14, 2022, titled ‘Zydus gets 180 day shared exclusivity for Roflumilast Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1004.00 2.15 (0.21%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.